↓ Skip to main content

Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States

Overview of attention for article published in The Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States
Published in
The Journal of Law, Medicine & Ethics, January 2021
DOI 10.1177/1073110516684803
Pubmed ID
Authors

Roojin Habibi, Line Guénette, Joel Lexchin, Ellen Reynolds, Mary Wiktorowicz, Barbara Mintzes

Abstract

Diverse legal and regulatory measures are used internationally to control the information provided during pharmaceutical sales visits. Little is known about the comparative effectiveness of these measures however. We analyzed the perceptions of regulators, pharmaceutical industry officials, health professionals, and consumer respondents concerning these approaches in Canada, France, and the United States using an empirical realist interests-based approach. Interviews focused on the aims and effectiveness of regulation, barriers and enablers to regulation and suggestions for improvement. An alignment was found in North America regulator and industry respondents' satisfaction with the status quo and their view that further intervention is unfeasible and unnecessary. Health professionals generally expressed a lack of confidence in the impact of regulations on sales visit information while consumer advocates voiced their disappointment in both regulators and health professionals for their failure to counteract the influence of pharmaceutical marketing. Regulator and industry respondents in France differed from their North American counterparts in their willingness to increase and diversify the scope of regulatory interventions. As the first international comparison of regulatory experiences in this sector, the findings highlight the universal need for more focused and inclusive discussions among groups about how to tailor regulations to achieve public health goals.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 24%
Researcher 6 16%
Student > Ph. D. Student 3 8%
Student > Doctoral Student 2 5%
Student > Bachelor 2 5%
Other 9 24%
Unknown 6 16%
Readers by discipline Count As %
Social Sciences 10 27%
Medicine and Dentistry 6 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 14%
Nursing and Health Professions 3 8%
Psychology 2 5%
Other 4 11%
Unknown 7 19%